Plasma TNF-a, interleukin-6 (IL-6) and IL-10 levels were higher in AML patients compared with ALL patients and control group and plasma levels of IL-6 and IL-10 were associated with patient survival and event-free survival. This evidence concerns the gene IL10 and acute myeloid leukemia.